| | | ETHYL 8-OXO-1,4,5,6,7,8-HEXAHYDROCYCLOHEPTA[B]PYRROLE-2-CARBOXYLATE
CAS:1979149-35-3
Formula: C12H15NO3
BB015298
8-oxo-4,5,6,7-tetrahydro-1H-cyclohepta[b]pyrrole-2-carboxylic acid ethyl ester; ethyl 8-oxo-4,5,6,7-tetrahydro-1H-cyclohepta[b]pyrrole-2-carboxylate ETHYL BREVIFOLINCARBOXYLATE
CAS:107646-82-2
Formula: C15H12O8
GëÑ95%
NP4947
Cyclopenta[c][2]benzopyran-1-carboxylic acid, 1,2,3,5-tetrahydro-7,8,9-trihydroxy-3,5-dioxo-, ethyl ester; Ethyl 7,8,9-trihydroxy-3,5-dioxo-1,2,3,5-tetrahydrocyclopenta[c]isochromene-1-carboxylate; EBFC; ethylbrevifolin carboxylate; 7,8,9-T ETHYL HEXAHYDROPYRROLO[3,4-B]PYRROLE-5(1H)-CARBOXYLATE
CAS:132414-79-0
Formula: C9H16N2O2
BB007585
2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylic acid ethyl ester; ethyl 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate ETHYL NICOTINATE-1,2',3',4',5',6'-[13C6] HYDROCHLORIDE SALT
CAS:1346604-87-2
Formula: C2[13C]6H9NO2.HCl
GëÑ90%
BLP-006313
Ethyl Nicotinate-1,2',3',4',5',6'-13C6 Hydrochloride Salt; Nikithan-13C6; 3-Pyridinecarboxylic Acid-13C6 Ethyl Ester Hydrochloride; 3-(Ethoxycarbonyl)pyridine-13C6 Hydrochloride; 3-Carbethoxypyridine-13C6 Hydrochloride; Ethyl 3-Pyridinecarb ETHYL PRAMIPEXOLE
CAS:1254579-15-1
Formula: C9H15N3S
> 95%
1254579-15-1
Ethyl Pramipexole; 1254579-15-1; HE8MT7V38V; 2,6-Benzothiazolediamine, N6-ethyl-4,5,6,7-tetrahydro-, (6S)-; (6S)-6-N-Ethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; UNII-HE8MT7V38V; SCHEMBL8244275; CS-0165697; 2,6-Benzothiazolediami Ethyl trans-apovincaminate
CAS:77549-94-1
Formula: C22H26N2O2
GëÑ95%
77549-94-1
(3R,16S)-Vinpocetine; trans-Apovincaminic acid ethyl ester; Eburnamenine-14-carboxylic acid, ethyl ester, (16+¦)-; Ethyl (16+¦)-eburnamenine-14-carboxylic acid; Ethyl (3R,16S)-apovincaminate; Ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydr ETHYL VINCAMINATE N-OXIDE
CAS:52341-36-3
Formula: C22H28N2O4
52341-36-3
Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, ethyl ester, 4-oxide, (3-alpha,14-beta,16-alpha)-; (41S,12S,13aS)-12-(ethoxycarbonyl)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydroindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphth ETHYL-3-AMINO-4,4,4-TRIFLUORO-2-BUTENOATE
CAS:141860-78-8
Formula: C6H8F3NO2
BB066113
Ethyl 3-amino-4,4,4-trifluorocrotonate; ethyl 3-amino-4,4,4-trifluorobut-2-enoate; ethyl (Z)-3-amino-4,4,4-trifluorobut-2-enoate; 3-Amino-4,4,4-trifluorocrotonic Acid Ethyl Ester; (Z)-3-Amino-4,4,4-trifluorocrotonic acid ethyl ester; ethyl- ETHYLBORONIC ACID PINACOL ESTER
CAS:82954-89-0
Formula: C8H17O2B
BB036942
2-ethyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; 2-ethyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Ethynyl Estradiol Dimer Impurity 1
CAS:303014-90-6
Formula: C40H46O4
GëÑ95%
303014-90-6
Ethinyl estradiol 4-oxy dimer; 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, 4-[[(17+¦)-17-hydroxy-19-norpregna-1,3,5(10)-trien-20-yn-3-yl]oxy]-, (17+¦)-; Ethinylestradiol 4-Oxy Dimer; Ethinyl Estradiol Dimer Impurity; (8R,9S,13S,14S,17R)-17 Ethynyl Estradiol Dimer Impurity 2
CAS:303014-91-7
Formula: C40H46O4
GëÑ95%
303014-91-7
19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, 2-[[(17+¦)-17-hydroxy-19-norpregna-1,3,5(10)-trien-20-yn-3-yl]oxy]-, (17+¦)-; Ethinyl estradiol 2-oxy dimer; Ethinylestradiol 2-Oxy Dimer; (8R,9S,13S,14S,17R)-17-Ethynyl-2-(((8R,9S,13S,14S,17R)-1 ETHYNYLBORONIC ACID PINACOL ESTER
CAS:347389-74-6
Formula: C8H13O2B
BB022266
2-ethynyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; 2-ethynyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane ETHYNYLESTRADIOL IMPURITY 1
Formula: C22H26O4
> 95%
(6R,13S,16S,17S)-16-ethynyl-3,6-dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate ETHYNYLESTRADIOL IMPURITY M
CAS:1818-11-7
Formula: C21H24O2
> 95%
1818-11-7
(8R,9S,13S,14S,17S)-3-cyanato-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ol ETOPOSIDE D-GLUCURONIDE
CAS:100007-55-4
Formula: C35H40O19
100007-55-4
Etoposide glucuronide; 100007-55-4; F65IJO84A1; (2S,3S,4S,5R,6S)-6-[4-[(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6 ETOPOSIDE EP IMPURITY B
CAS:100007-56-5
Formula: C29H32O13
>95%
100007-56-5
cis-Etoposide; (5R,5aS,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-+¦-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, ETOPOSIDE EP IMPURITY C
CAS:100007-53-2
Formula: C29H32O13
>95%
100007-53-2
+¦-Etoposide; (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-+¦-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9 ETOPOSIDE IMPURITY D
CAS:23363-35-1
Formula: C27H30O13
> 95%
23363-35-1
Lignan P; (5R,5aR,8aR,9S)-9-(+¦-D-Glucopyranosyloxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-uro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; ETOPOSIDE PHOSPHATE DIAMMONIUM SALT
Formula: C29H31O16P.2NH4
(5R,5aR,8aR,9S)-5-[3,5-Dimethoxy-4-(phosphonooxy)phenyl]-9-[[4,6-O-(1R)-ethylidene-+¦-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one diammonium salt; Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5a Etoposide-[13C,d3]
Formula: C28[13C]H29D3O13
B1370-175035
(5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-+¦-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one-13C-d3 ETOPOSIDE-[D3]
Formula: C29H29D3O13
96% by CP; 99% atom D
BLP-006081
(5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-+¦-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one-d3; Etoposide D3 EUGLOBAL IA1
CAS:77844-93-0
Formula: C23H30O5
92.0%
NP4486
Euglobal Ia1; euglobal IA2; 77794-63-9; 77844-93-0; 1,3-dihydroxy-10a-methyl-9-(2-methylpropyl)-7-propan-2-yl-7,8,8a,9-tetrahydroxanthene-2,4-dicarbaldehyde; 1H-Xanthene-5,7-dicarboxaldehyde, 2,4a,9,9a-tetrahydro-6,8-dihydroxy-4a-methyl-2-( EUOJAPONINE D
CAS:128397-42-2
Formula: C41H47NO17
>98%
B0005-053680
19,22,23-Tris(acetyloxy)-21-[(acetyloxy)methyl]-25,26-dihydroxy-3,15,26-trimethyl-6,16-dioxo-2,5,17-trioxa-11-azapentacyclo[16.7.1.0~1,21~.0~3,24~.0~7,12~]hexacosa-7,9,11-trien-20-yl benzoate EUPAGLEHNIN C
CAS:476630-49-6
Formula: C20H26O5
NP5705
[(3aR,4R,6Z,10E,11aR)-6,10-dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] (Z)-2-(hydroxymethyl)but-2-enoate EUPAHUALIN C
CAS:108525-39-9
Formula: C20H24O6
108525-39-9
(E)-4-Hydroxy-2-methyl-2-butenoic acid (3aR,4R,6E,10E,11aR)-2-oxo-3-methylene-6-formyl-10-methyl-2,3,3a,4,5,8,9,11a-octahydrocyclodeca[b]furan-4alpha-yl ester EUPALINILIDE B
CAS:757202-08-7
Formula: C20H24O6
>98%
757202-08-7
EUPALINILIDE B; 757202-08-7; [(3aR,4R,6aR,9R,9aS,9bS)-9-hydroxy-9-methyl-3,6-dimethylidene-2-oxo-3a,4,5,6a,9a,9b-hexahydroazuleno[4,5-b]furan-4-yl] (E)-4-hydroxy-2-methylbut-2-enoate; Eupalinilide-B; CHEMBL463969; HY-N6955; AKOS040760389; C EUPALINOLIDE A
CAS:877822-41-8
Formula: C24H30O9
>98%
877822-41-8
2-Butenoic acid, 4-hydroxy-2-methyl-, (3aR,4R,6Z,9S,10E,11aR)-9-(acetyloxy)-6-[(acetyloxy)methyl]-2,3,3a,4, 5,8,9,11a-octahydro-10-methyl-3-methylene-2-oxocyclodeca[b]furan-4- yl ester, (2E)- EUPALINOLIDE C
CAS:1000865-06-4
Formula: C22H28O8
GëÑ95%
1000865-06-4
2-Butenoic acid, 4-hydroxy-2-methyl-, (3aR,4R,6E,9S,10Z,11aR)-9-(acetyloxy)-2,3,3a,4,5,8,9,11a-octahydro-6-(hydroxymethyl)-10-methyl-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, (2E)-; (E)-2-Methyl-4-hydroxy-2-butenoic acid [(3aR,4R,6Z,9S EUPATOLIDE
CAS:6750-25-0
Formula: C15H20O3
GëÑ95%
NP5677
Cyclodeca[b]furan-2(3H)-one, 3a,4,5,8,9,11a-hexahydro-4-hydroxy-6,10-dimethyl-3-methylene-, (3aR,4R,6E,10E,11aR)-; (3aR,4R,6E,10E,11aR)-4-Hydroxy-6,10-dimethyl-3-methylene-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-2(3H)-one EUPATORIOPICRIN
CAS:6856-01-5
Formula: C20H26O6
97.5%
NP5759
[(3aR,4R,6Z,10E,11aR)-6,10-dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] (E)-4-hydroxy-2-(hydroxymethyl)but-2-enoate EUPENIFELDIN
CAS:151803-45-1
Formula: C33H40O7
BBF-03519
(6aR*,8E,11aS*,18aR*,19R*,20aR*)-6a,7,10,11,11a,18a,19,20,20a,21-Decahydro-4,16,19-trihydroxy-1,6a,10,13,18a-hexamethyl-3H-dicyclohepta(e,e')cycloundeca(1,2-b:5,6-b')dipyran-3,15(12H)-dione EUPHOHELIOSCOPIN A
CAS:87064-61-7
Formula: C30H42O6
96.5%
NP1734
(1aR,2Z,4aR,6R,7S,7aS,8Z,10R,11aS)-4a-Acetoxy-7-hydroxy-1,1,3,6,9-pentamethyl-4-oxo-1a,4,4a,5,6,7,7a,10,11,11a-decahydro-1H-cyclopenta[a]cyclopropa[f][11]annulen-10-yl (2E,4Z)-2,4-octadienoate EUPHORBIA FACTOR L1
CAS:76376-43-7
Formula: C32H40O8
>=98%
NP1512
(1aR,4aR,6S,7S,7aR,8S,9R,11aS)-4a,8-Diacetoxy-1,1,3,6-tetramethyl-4-oxo-1,1a,4,4a,5,6,7,7a,8,10,11,11a-dodecahydrospiro[cyclopenta[a]cyclopropa[f][11]annulene-9,2'-oxiran]-7-yl phenylacetate; 10-epi-Eupatoroxin EUPHORBIASTEROID
CAS:28649-59-4
Formula: C32H40O8
>98%
28649-59-4
(1aS,2E,4aR,6S,7S,7aS,8S,9R,11aS)-4a,8-bis(acetyloxy)-1,1,3,6-tetramethyl-4-oxo-1,1a,4,4a,5,6,7,7a,8,10,11,11a-dodecahydrospiro[cyclopenta[a]cyclopropa[f][11]annulene-9,2'-oxiran]-7-yl phenylacetate EUPHORNIN
CAS:80454-47-3
Formula: C33H44O9
80454-47-3
3aH-Cyclopentacyclododecene-1,3a,4,9,11-pentol, 1,2,3,4,5,8,9,10,11,13a-decahydro-2,5,8,8,12-pentamethyl-, 4,9,11-triacetate 1-benzoate, (1S,2S,3aR,4S,5S,6E,9R,11R,12E,13aS)- Euphoscopin B
CAS:81557-52-0
Formula: C33H42O9
81557-52-0
8H-Cyclopentacyclododecen-8-one, 6,13,13a-tris(acetyloxy)-3-(benzoyloxy)-1,2,3,3a,6,7,9,12,13,13a-decahydro-2,5,9,9,12-pentamethyl-, (2R,3S,3aS,4E,6R,10E,12R,13R,13aR)-; (2R,3S,3aS,4E,6R,10E,12R,13R,13aR)-6,13,13a-Tris(acetyloxy)-3-(benzoyl EURYCOMALACTONE
CAS:23062-24-0
Formula: C19H24O6
98%
23062-24-0
Eurycomalactone; 23062-24-0; EURYCOMALACTONE(P); CHEBI:4944; (1S,2R,5S,9S,10S,11R,12R,13R,16R)-9,12-dihydroxy-2,6,10,16-tetramethyl-14-oxatetracyclo[11.2.1.02,11.05,10]hexadec-6-ene-3,8,15-trione; 1H-Phenanthro(10,1-bc)furan-4,6,9(2H,5aH,6a Eurycomanol-2-O-beta-D-glucopyranoside
CAS:126260-97-7
Formula: C26H36O14
98%
126260-97-7
Picras-3-en-16-one, 11,20-epoxy-2-(+¦-D-glucopyranosyloxy)-1,11,12,14,15-pentahydroxy-, (1+¦,2+¦,11+¦,12+¦,15+¦)-; (1+¦,2+¦,11+¦,12+¦,15+¦)-11,20-Epoxy-2-(+¦-D-glucopyranosyloxy)-1,11,12,14,15-pentahydroxypicras-3-en-16-one; Eurycomanol 2-O-+¦-D-glucopy EUSCAPHIN B
CAS:956869-95-7
Formula: C14H26O4
NP5632
(1S,3R,6S)-6-[(E,3R)-3-hydroxybut-1-enyl]-6-methoxy-1,5,5-trimethylcyclohexane-1,3-diol;1,3-Cyclohexanediol, 6-[(1E,3S)-3-hydroxy-1-buten-1-yl]-6-methoxy-1,5,5-trimethyl-, (1S,3R,6S)- EVEROLIMUS EP IMPURITY C
Formula: C52H81NO14
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18,19-trihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-30-methoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatri EVEROLIMUS EP IMPURITY D
Formula: C53H83NO14
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1-hydroxy-18-(2-hydroxyethoxy)-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9] EVEROLIMUS EP IMPURITY E
CAS:1237826-25-3
Formula: C52H79NO14
1237826-25-3
(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-y EVEROLIMUS EP IMPURITY F
Formula: C55H89NO16
(1R,9S,12S,15R,16E,18R,19S,20R,21R,23S,24S,25E,27+P,28E,30S,32S,35R)-27-ethoxy-1,18,20-trihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36,37-trioxa-4-azat EVEROLIMUS HYDROLIZED IMPURITY
CAS:769905-89-7
Formula: C53H85NO15
> 95%
769905-89-7
seco Everolimus B; (2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1- EVEROLIMUS RELATED COMPOUND 3
CAS:147438-30-0
Formula: C32H49NO9
95%
147438-30-0
(2S)-1-[[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-Dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrienyl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]oxoacetyl]-2-piperidinecarboxylic Acid EVEROLIMUS RELATED COMPOUND 4
Formula: C57H91NO16
> 95%
(2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hyd Evixapodlin
CAS:2374856-75-2
Formula: C34H36Cl2N8O4
GëÑ98%
2374856-75-2
(12S,122S)-62,72-dichloro-53,86-dimethoxy-3,10-diaza-5,8(2,5)-dipyrazina-1,12(2)-dipyrrolidina-6,7(1,3)-dibenzenadodecaphane-15,125-dione; (5S,5'S)-5,5' EVODOL
CAS:22318-10-1
Formula: C26H28O9
> 95%
NP6688
(4bR,10bR)-2,4,4a,5a+¦,6,8,8a,9,10,10a+¦,14,14a+¦-Dodecahydro-2,2,4a+¦,8a+¦-tetramethyl-8+¦-(3-furanyl)-3-hydroxy-13H-oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13-trione; [(3S,8S,9S,10R,13S,14S,16R,17R)-17-acetyl-16-(azirid EXALITE 417
CAS:188652-86-0
Formula: C63H74
188652-86-0
7,7''-Bis(2,2-dimethylpropyl)-9,9,9',9',9'',9''-hexapropyl-2,2',7',2''-ter-9H-fluorene EXALITE 428
CAS:188652-87-1
Formula: C73H78
188652-87-1
2,2':7',2''-Ter-9H-fluorene, 7,7''-bis[4-(1,1-dimethylethyl)phenyl]-9,9,9',9',9'',9''-hexapropyl- EXATECAN
CAS:171335-80-1
Formula: C24H22FN3O4
GëÑ95%
BBF-05828
DX-8951; (1S,9S)-1-Amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10H,13H-benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione; 10H,13H-Benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino Exatecan hydrochloride
CAS:144008-87-7
Formula: C24H22FN3O4.HCl
GëÑ95%
BADC-01405
10H,13H-Benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, monohydrochloride, (1S,9S)-; 10H,13H-Benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13- EXATECAN MESYLATE
CAS:169869-90-3
Formula: C25H26FN3O7S
>98%
BBF-04655
DX 8951 mesylate; (1S,9S)-1-Amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10H,13H-benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione mesylate; 10H,13H-Benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10 Exemestane-[13C,d4]
Formula: C19[13C]H20D4O2
>95%
BLP-015193
(8R,9S,10R,13S,14S)-10,13-dimethyl-6-(methylene-13C-d2)-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione-16,16-d2; Exemestane 13C D4; Aromasin-13C,d4; 6-Methyleneandrosta-1,4-diene-3,17-dione-13C,d4; Aromasin Exemestane-[d2]
Formula: C20H22D2O2
99.6% by HPLC; 99% atom D
BLP-013940
6-Methyleneandrosta-1,4-diene-3,17-dione-16,16-D2; Exemestane D2; (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione-16,16-d2; Aromasin-d2; Aromasine-d2; Exemestan Exemestane-[d4]
Formula: C20H20D4O2
>95%
BLP-015068
(8R,9S,10R,13S,14S)-10,13-Dimethyl-6-(methylene-d2)-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione-16,16-d2; Exemestane D4; Aromasin-d4; 6-Methyleneandrosta-1,4-diene-3,17-dione-d4; Aromasine-d4; Exemestano EXIFONE
CAS:52479-85-3
Formula: C13H10O7
95%
52479-85-3
2,3,3',4,4',5'-Hexahydroxybenzophenone; 2,3,4,3',4',5'-Hexahydroxybenzophenone; 3,4,5,2',3',4'-Hexahydroxybenzophenone; 4-Galloylpyrogallol; Adlone; NSC 680919; Methanone, (2,3,4-trihydroxyphenyl)(3,4,5-trihydroxyphenyl)- EXO-5,6-OXI-2,3-NORBORNANEDICARBOXAMIDE
CAS:85026-47-7
Formula: C9H9NO3
BB058683
(1aR,2R,2aS,5aR,6S,6aS)-Tetrahydro-1aH-2,6-methanooxireno[2,3-f]isoindole-3,5(4H,5aH)-dione EXO-IWR 1
CAS:1127442-87-8
Formula: C25H19N3O3
GëÑ99% by HPLC
1127442-87-8
rel-4-[(3aR,4R,7S,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide; 4-[(3aR,4R,7S,7aS-rel)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide EXOTICIN
CAS:13364-94-8
Formula: C23H26O10
0.97
NP2121
3,3',4',5,5',6,7,8-octamethoxyflavone; 3,5,6,7,8-Pentamethoxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-on e Ezetimibe diastereomers
Formula: C24H21F2NO3
GëÑ95%
Ezetimibe R,R,R- and S,S,S-isomer; R,R,R-Ezetimibe and S,S,S-Ezetimibe; (3S,4S)-1-(4-Fluorophenyl)-3-[(S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one and (3R,4R)-1-(4-Fluorophenyl)-3-[(R)-3-(4-fluorophenyl)-3-hydro Ezetimibe-[d4] O-Beta-Glucuronide
Formula: C30H25D4F2NO9
>95%
BLP-015070
(2S,3S,4S,5R,6S)-6-(4-((2S,3R)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl-2,3,5,6-d4)-3-hydroxypropyl)-4-oxoazetidin-2-yl)phenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; Ezetimibe D4-O-Beta-Glucuronide; Ezetimibe-d4 glucuro F-10748 C1
Formula: C42H62O16
BBF-02825
2,4,12-Hexadecatrienoic acid, 7-hydroxy-8,14-dimethyl-, 3',4',5',6'-tetrahydro-3',5,7-trihydroxy-6'-(hydroxymethyl)-5'-[[6-O-(1-oxopentyl)hexopyranosyl]oxy]spiro[isobenzofuran-1(3H),2'-[2H]pyran]-4'-y l ester, (2E,4E,12E)- F-CPR-II CEP
CAS:1027512-47-5
Formula: C49H54F17N2O9P
BB063359
2- [[[[Bis(1- methylethyl) amino] (2- cyanoethoxy) phosphino] oxy] methyl] - 2- [[[4- (3, 3, 4, 4, 5, 5, 6, 6, 7, 7, 8, 8, 9, 9, 10, 10, 10- heptadecafluorodecyl ) phenyl] bis(4- methoxyphenyl) methoxy] methyl] - 1, 3- diethyl Ester Propane F1839-I
CAS:159096-49-8
Formula: C23H32O4
GëÑ98%
BBF-04384
F1839-I;159096-49-8;(3R,4aS,7R,8R,8aS)-3,4'-dihydroxy-4,4,6',7,8a-pentamethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3H-1-benzofuran]-7'-carbaldehyde;CHEMBL3092716;CHEBI:204378;HY-N11430;AKOS040761725;DA-73285;CS-0646802;(2R,2'R,4' FABIATRIN
CAS:18309-73-4
Formula: C21H26O13
>98%
B0005-053669
6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-one FACTUMYCIN
CAS:84600-89-5
Formula: C44H62N2O10
BBF-03482
Antibiotic A 40A; Mocimycin, 14,17-deepoxy-14,15-didehydro-15,30-dideoxy-17-hydroxy-1-methyl-, (14Z)-; 2H-Pyran-2-acetamide, N-[(2E,4E,6S,7S,9S,10E,12E,14E,16E)-18-(1,2-dihydro-4-hydroxy-1-methyl-2-oxo-3-pyridinyl)-8,9-dihydroxy-6-methoxy-5 FADROZOLE
CAS:102676-47-1
Formula: C14H13N3
95%
102676-47-1
Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-; CGS 16949A (free base); 5-p-cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine; 4-{5H,6H,7H,8H-imidazo[1,5-a]pyridin-5-yl}benzonitrile FADROZOLE HYDROCHLORIDE
CAS:102676-31-3
Formula: C14H14ClN3
99%
102676-31-3
Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-, hydrochloride (1:1); Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-, monohydrochloride; Afema; CGS 16949; CGS 16949A FAK INHIBITOR 5
CAS:1426683-30-8
Formula: C20H21N3O2S
GëÑ95%
1426683-30-8
1-Ethyl-8-(4-ethylphenyl)-5-methyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazine 4,4-dioxide; Pyrazolo[4,3-c][2,1]benzothiazine, 1-ethyl-8-(4-ethylphenyl)-1,5-dihydro-5-methyl-, 4,4-dioxide FAK-IN-1
CAS:2553215-22-6
Formula: C24H26F3N7O4S
2553215-22-6
10H-Pyrimido[5,4-b]thiazolo[5,4-e][1,4]diazepin-10-one, 4,9-dihydro-2,4,9-trimethyl-6-[(1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinyl)amino]-, 2,2,2-trifluoroacetate (1:1) FALCARINDIOL
CAS:55297-87-5
Formula: C17H24O2
>98%
NP4280
1,9-Heptadecadiene-4,6-diyne-3,8-diol, (3S,8S,9Z)-; (3S,8S,9Z)-1,9-Heptadecadiene-4,6-diyne-3,8-diol; 1,9-Heptadecadiene-4,6-diyne-3,8-diol, [S-[R*,R*-(Z)]]-; (+)-Falcarindiol; (3S,8S)-Falcarindiol; (3S,8S,Z)-heptadeca-1,9-dien-4,6-diyne-3, |
